SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

All are welcome to join the Options Medical Weight Loss team and the Cary Chamber of ... we're proud that within six months, the average patient loses 30 pounds of fat, including 21 percent ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...

A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...

Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.O ...

The lowest dose of Novo Nordisk's weight-loss drug, Wegovy, was listed as available on the U.S. health regulator's website on Wednesday.

All are welcome to join the Options Medical Weight Loss team and the Cary Chamber of Commerce for grand re-opening festivities, October 23 ST. PETERSBURG, Fla., Oct. 21, 2024 /PRNewswire ...